Estibaliz Miranda

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.

Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.

Journal: British journal of haematology
Published: December 16, 2025

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

Journal: Blood
Published: April 01, 2025

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Journal: Blood
Published: April 01, 2025

BET inhibitors downregulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1.

BET inhibitors downregulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1.

Journal: Haematologica
Published: May 29, 2024

HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice.

HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice.

Journal: Bone & joint research
Published: April 15, 2024

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Journal: Nature communications
Published: February 02, 2023

Identifying Lethal Dependencies with HUGE Predictive Power.

Identifying Lethal Dependencies with HUGE Predictive Power.

Journal: Cancers
Published: May 16, 2022

Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts.

Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts.

Journal: American journal of hematology
Published: September 09, 2021

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

Journal: Journal of medicinal chemistry
Published: March 04, 2021

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma.

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma.

Journal: Leukemia
Published: June 25, 2020

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Journal: Genome research
Published: May 08, 2020

Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated.

Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated.

Journal: Haematologica
Published: August 23, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026